01 3ABBVIE
01 311690845
01 3Blank
01 3Blank
01 32040-08-27
Patent Expiration Date : 2040-08-27
US Patent Number : 11690845
Drug Substance Claim :
Drug Product Claim :
Application Number : 210450
Patent Use Code : U-3654
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2040-08-27
Patent Expiration Date : 2040-08-27
US Patent Number : 11690845
Drug Substance Claim :
Drug Product Claim :
Application Number : 210450
Patent Use Code : U-3654
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2040-08-27
Patent Expiration Date : 2040-08-27
ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE; ELAGOLIX SODIUM
US Patent Number : 11690845
Drug Substance Claim :
Drug Product Claim :
Application Number : 213388
Patent Use Code : U-3655
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2040-08-27
